Neurophysiological alterations in the prepsychotic phases

Current Pharmaceutical Design

Volumn 18, Issue 4, 2012, Pages 479-785

  Crossley, Nicolas A ^a   Constante, Miguel ^a   Fusar Poli, Paolo ^a   Bramon, Elvira ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

EEG; ERP; Prodrome; Psychosis

Indexed keywords

ELECTROPHYSIOLOGY; EVENT RELATED POTENTIAL; HIGH RISK POPULATION; HUMAN; MISMATCH NEGATIVITY; NEUROPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SENSORY GATING;

BRAIN; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; HUMANS; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS;

EID: 84856534686     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212799316307     Document Type: Review

References (61)

1. Broome MR, Woolley JB, Johns LC, et al. Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state. Eur Psychiatry 2005; 20(5-6): 372-8.
2. Yung AR, Yuen HP, McGorry PD, et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry 2005; 39(11-12): 964-71.
3. Schultze-Lutter F, Ruhrmann S, Berning J, Maier W, Klosterkotter J. Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophrenia Bulletin 2010; 36(1): 182-91.
4. Yung AR, Yuen HP, Berger G, et al. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 2007; 33(3): 673-81.
5. Cannon TD, Cadenhead K, Cornblatt B, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 2008; 65(1): 28-37.
6. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 2007; 118(10): 2128-48.
7. McCarthy G, Wood CC, Williamson PD, Spencer DD. Taskdependent field potentials in human hippocampal formation. J Neurosci. 1989; 9(12): 4253-68.
8. Halgren E, Baudena P, Clarke JM, et al. Intracerebral potentials to rare target and distractor auditory and visual stimuli. I. Superior temporal plane and parietal lobe. Electroencephalogr Clin Neurophysiol. 1995; 94(3): 191-220.
9. Alain C, Richer F, Achim A, Saint Hilaire JM. Human intracerebral potentials associated with target, novel, and omitted auditory stimuli. Brain Topogr. 1989; 1(4): 237-45.
10. Bledowski C, Prvulovic D, Hoechstetter K, et al. Localizing P300 generators in visual target and distractor processing: a combined event-related potential and functional magnetic resonance imaging study. J Neurosci 2004; 24(42): 9353-60.
11. Bramon E, Rabe-Hesketh S, Sham P, Murray RM, Frangou S. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res 2004; 70(2-3): 315-29.
12. Hirayasu Y, Asato N, Ohta H, Hokama H, Arakaki H, Ogura C. Abnormalities of auditory event-related potentials in schizophrenia prior to treatment. Biol Psychiatry. 1998; 43(4): 244-53.
13. Salisbury DF, Shenton ME, Sherwood AR, et al. First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe. Arch Gen Psychiatry. 1998; 55(2): 173-80.
14. Bramon E, McDonald C, Croft RJ, et al. Is the P300 wave an endophenotype for schizophrenia? A meta-analysis and a family study. NeuroImage 2005; 27(4): 960-8.
15. Hall MH, Rijsdijk F, Kalidindi S, et al. Genetic overlap between bipolar illness and event-related potentials. Psychol Med 2007; 37(5): 667-78.
16. McCarley RW, Salisbury DF, Hirayasu Y, et al. Association between smaller left posterior superior temporal gyrus volume onmagnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia. Arch Gen Psychiatry 2002; 59(4): 321-31.
17. Schulze KK, Hall MH, McDonald C, et al. Auditory P300 in patients with bipolar disorder and their unaffected relatives. Bipolar Disord 2008; 10(3): 377-86.
18. Hall MH, Schulze K, Rijsdijk F, et al. Are auditory P300 and duration MMN heritable and putative endophenotypes of psychotic bipolar disorder? A Maudsley Bipolar Twin and Family Study. Psychol Med 2009; 39(8): 1277-87.
19. Bramon E, Dempster E, Frangou S, et al. Neuregulin-1 and the P300 waveform--a preliminary association study using a psychosis endophenotype. Schizophr Res 2008; 103(1-3): 178-85.
20. van der Stelt O, Lieberman JA, Belger A. Auditory P300 in highrisk, recent-onset and chronic schizophrenia. Schizophr Res 2005; 77(2-3): 309-20.
21. Bramon E, Shaikh M, Broome M, et al. Abnormal P300 in people with high risk of developing psychosis. NeuroImage 2008; 41(2): 553-60.
22. Frommann I, Brinkmeyer J, Ruhrmann S, et al. Auditory P300 in individuals clinically at risk for psychosis. Int J Psychophysiol 2008; 70(3): 192-205.
23. Ozgurdal S, Gudlowski Y, Witthaus H, et al. Reduction of auditory event-related P300 amplitude in subjects with at-risk mental state for schizophrenia. Schizophr Res 2008; 105(1-3): 272-8.
24. van Tricht MJ, Nieman DH, Koelman JH, et al. Reduced parietal P300 amplitude is associated with an increased risk for a first psychotic episode. Biol Psychiatry 2010; 68(7): 642-8.
25. Hafner H, Maurer K, Ruhrmann S, et al. Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci 2004; 254(2): 117-28.
26. Fusar-Poli P, Crossley N, Woolley J, et al. Gray matter alterations related to P300 abnormalities in subjects at high risk for psychosis: longitudinal MRI-EEG study. NeuroImage 2011; 55(1): 320-8.
27. van Tricht MJ, Nieman DH, Koelman JH, et al. Auditory ERP components before and after transition to a first psychotic episode. Biol Psychol 2011.
28. Jeon YW, Polich J. P300 asymmetry in schizophrenia: a metaanalysis. Psychiatry Res 2001; 104(1): 61-74.
29. Maeshima S, Okita R, Yamaga H, Ozaki F, Moriwaki H. Relationships between event-related potentials and neuropsychological tests in neurologically healthy adults. J Clin Neurosci 2003; 10(1): 60-2.
30. Fusar-Poli P, Crossley N, Woolley J, et al. White matter alterations related to P300 abnormalities in individuals at high risk for psychosis: an MRI-EEG study. Journal of psychiatry & neuroscience: JPN 2011; 36(4): 239-48.
31. Stone JM, Bramon E, Pauls A, Sumich A, McGuire PK. Thalamic neurochemical abnormalities in individuals with prodromal symptoms of schizophrenia - relationship to auditory event-related potentials. Psychiatry Res 2010; 183(2): 174-6.
32. Kumari V, Soni W, Mathew VM, Sharma T. Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication. Arch Gen Psychiatry 2000; 57(6): 609-14.
33. Makela JP, Hamalainen M, Hari R, McEvoy L. Whole-head mapping of middle-latency auditory evoked magnetic fields. Electroencephalogr Clin Neurophysiol. 1994; 92(5): 414-21.
34. Weisser R, Weisbrod M, Roehrig M, Rupp A, Schroeder J, Scherg M. Is frontal lobe involved in the generation of auditory evoked P50? Neuroreport 2001; 12(15): 3303-7.
35. Chang WP, Arfken CL, Sangal MP, Boutros NN. Probing the relative contribution of the first and second responses to sensory gating indices: A meta-analysis. Psychophysiology 2011; 48(7): 980-92.
36. Hall MH, Rijsdijk F, Picchioni M, et al. Substantial shared genetic influences on schizophrenia and event-related potentials. Am J Psychiatry 2007; 164(5): 804-12.
37. Hall MH, Schulze K, Sham P, et al. Further evidence for shared genetic effects between psychotic bipolar disorder and P50 suppression: a combined twin and family study. Am J Med Genet B Neuropsychiatr Genet 2008; 147B(5): 619-27.
38. Cadenhead KS, Light GA, Geyer MA, Braff DL. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry 2000; 157(1): 55-9.
39. Myles-Worsley M, Ord L, Blailes F, Ngiralmau H, Freedman R. P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia. Biol Psychiatry 2004; 55(7): 663-7.
40. Cadenhead KS, Light GA, Shafer KM, Braff DL. P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Biol Psychiatry 2005; 57(12): 1504-9.
41. Hong X, Chan RC, Zhuang X, et al. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia. Schizophr Res 2009; 108(1-3): 151-7.
42. Brockhaus-Dumke A, Schultze-Lutter F, Mueller R, et al. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients. Biol Psychiatry 2008; 64(5): 376-84.
43. Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58(2): 158-64.
44. Rosburg T, Boutros NN, Ford JM. Reduced auditory evoked potential component N100 in schizophrenia--a critical review. Psychiatry Res 2008; 161(3): 259-74.
45. Naatanen R, Paavilainen P, Rinne T, Alho K. The mismatch negativity (MMN) in basic research of central auditory processing: a review. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology 2007; 118(12): 2544-90.
46. Rosburg T, Trautner P, Dietl T, et al. Subdural recordings of the mismatch negativity (MMN) in patients with focal epilepsy. Brain 2005; 128(Pt 4): 819-28.
47. Park HJ, Kwon JS, Youn T, et al. Statistical parametric mapping of LORETA using high density EEG and individual MRI: application to mismatch negativities in schizophrenia. Hum Brain Mapp 2002; 17(3): 168-78.
48. Opitz B, Rinne T, Mecklinger A, von Cramon DY, Schroger E. Differential contribution of frontal and temporal cortices to auditory change detection: fMRI and ERP results. NeuroImage 2002; 15(1): 167-74.
49. Umbricht D, Krljes S. Mismatch negativity in schizophrenia: a meta-analysis. Schizophr Res 2005; 76(1): 1-23.
50. Light GA, Braff DL. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Arch Gen Psychiatry 2005; 62(2): 127-36.
51. Salisbury DF, Kuroki N, Kasai K, Shenton ME, McCarley RW. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry 2007; 64(5): 521-9.
52. Niznikiewicz MA, Spencer KM, Dickey C, et al. Abnormal pitch mismatch negativity in individuals with schizotypal personality disorder. Schizophr Res 2009; 110(1-3): 188-93.
53. Price GW, Michie PT, Johnston J, et al. A multivariate electrophysiological endophenotype, from a unitary cohort, shows greater research utility than any single feature in the Western Australian family study of schizophrenia. Biological Psychiatry 2006; 60(1): 1-10.
54. Bramon E, Croft RJ, McDonald C, et al. Mismatch negativity in schizophrenia: a family study. Schizophr Res 2004; 67(1): 1-10.
55. Shin KS, Kim JS, Kang DH, et al. Pre-attentive auditory processing in ultra-high-risk for schizophrenia with magnetoencephalography. Biol Psychiatry 2009; 65(12): 1071-8.
56. Brockhaus-Dumke A, Tendolkar I, Pukrop R, Schultze-Lutter F, Klosterkotter J, Ruhrmann S. Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia. Schizophr Res 2005; 73(2-3): 297-310.
57. Bodatsch M, Ruhrmann S, Wagner M, et al. Prediction of psychosis by mismatch negativity. Biological Psychiatry 2011; 69(10): 959-66.
58. Zimmermann R, Gschwandtner U, Wilhelm FH, Pflueger MO, Riecher-Rossler A, Fuhr P. EEG spectral power and negative symptoms in at-risk individuals predict transition to psychosis. Schizophr Res 2010; 123(2-3): 208-16.
59. Uhlhaas PJ, Haenschel C, Nikolic D, Singer W. The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia. Schizophr Bull 2008; 34(5): 927-43.
60. Miller TJ, McGlashan TH, Rosen JL, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 2002; 159(5): 863-5.
61. Gross G, Huber G, Klosterkoetter J, Linz M. Bonner Skala fur die Beurteilung von Basissymptomen (BSABS: Bonn Scale for theAssessment of Basic Symptoms). Berlin: Springer; 1987.